Exact Sciences Corporation
EXAS
$47.76
$0.811.73%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 706.79M | 713.42M | 708.66M | 699.26M | 637.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 706.79M | 713.42M | 708.66M | 699.26M | 637.52M |
| Cost of Revenue | 206.24M | 284.13M | 196.07M | 189.85M | 191.20M |
| Gross Profit | 500.55M | 429.29M | 512.59M | 509.42M | 446.32M |
| SG&A Expenses | 476.71M | 442.51M | 406.54M | 387.13M | 431.83M |
| Depreciation & Amortization | -- | -71.06M | 24.44M | 23.31M | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 788.26M | 755.20M | 727.15M | 721.17M | 733.90M |
| Operating Income | -81.47M | -41.77M | -18.50M | -21.91M | -96.38M |
| Income Before Tax | -100.99M | -875.97M | -37.43M | -14.35M | -108.42M |
| Income Tax Expenses | 224.00K | -11.38M | 808.00K | 1.46M | 1.81M |
| Earnings from Continuing Operations | -101.22M | -864.59M | -38.24M | -15.81M | -110.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -101.22M | -864.59M | -38.24M | -15.81M | -110.23M |
| EBIT | -81.47M | -41.77M | -18.50M | -21.91M | -96.38M |
| EBITDA | -27.41M | 11.37M | 36.28M | 31.09M | -42.43M |
| EPS Basic | -0.54 | -4.67 | -0.21 | -0.09 | -0.60 |
| Normalized Basic EPS | -0.29 | -0.14 | -0.06 | -0.07 | -0.34 |
| EPS Diluted | -0.54 | -4.67 | -0.21 | -0.09 | -0.60 |
| Normalized Diluted EPS | -0.29 | -0.14 | -0.06 | -0.07 | -0.34 |
| Average Basic Shares Outstanding | 186.81M | 185.31M | 184.80M | 184.31M | 182.35M |
| Average Diluted Shares Outstanding | 186.81M | 185.31M | 184.80M | 184.31M | 182.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |